Imaging of adult astrocytic brain tumours with 7 T MRI: preliminary results

PurposeIn this study tumour vascularity and necrosis of intracranial astrocytomas were compared using 7 T and 1.5 T magnetic resonance imaging (MRI).MethodsFifteen patients with histologically proven astrocytomas (WHO grades II–IV) were prospectively examined at 1.5 T (Magnetom Espree or Sonata) and 7 T (Magnetom 7 T, Siemens, Erlangen, Germany) with T2*-w (weighted), T1-w with (only a subset of five patients at 7 T) and without contrast medium, T2-w and proton-density (PD)-w MRI. Clinically used 1.5 T sequences were adapted to 7 T. Histological findings and T2*-w MR images at both field strengths were compared for the presence of assumed tumour microvascularity and necrosis. Two diffusely infiltrating astrocytomas, four anaplastic astrocytomas and nine glioblastomas were included.ResultsT2*-w images depicted susceptibility patterns representing presumed tumour microvascularity in 8 out of 15 (53%) gliomas at 7 T compared with 5 out of 15 (33%) gliomas at 1.5 T. Compared with 1.5 T MRI three additional necrotic tumour areas were depicted only on 7 T T2- and T2*-w images of one glioblastoma. On T1-w MR images, contrast enhancement of five out of five glioblastomas was similar at both field strengths.Conclusion7 T gradient-echo sequences provide excellent image contrast of presumed microvasculature and necrosis in astrocytomas.

[1]  J. Folkman,et al.  Tumor angiogenesis: a quantitative method for histologic grading. , 1972, Journal of the National Cancer Institute.

[2]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[3]  D. Tank,et al.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Ogawa Brain magnetic resonance imaging with contrast-dependent oxygenation , 1990 .

[5]  C. Boring,et al.  Cancer statistics, 1990 , 1990, CA: a cancer journal for clinicians.

[6]  S. Ogawa,et al.  Magnetic resonance imaging of blood vessels at high fields: In vivo and in vitro measurements and image simulation , 1990, Magnetic resonance in medicine.

[7]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[8]  M. Neeman,et al.  Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. , 1995, Cancer research.

[9]  P. Robitaille,et al.  Macroscopic susceptibility in ultra high field MRI. , 1999, Journal of computer assisted tomography.

[10]  A. Kangarlu,et al.  High resolution MRI of the deep brain vascular anatomy at 8 Tesla: susceptibility-based enhancement of the venous structures. , 1999, Journal of computer assisted tomography.

[11]  A. Kangarlu,et al.  Human leptomeningeal and cortical vascular anatomy of the cerebral cortex at 8 Tesla. , 1999, Journal of computer assisted tomography.

[12]  A. Kangarlu,et al.  Macroscopic susceptibility in ultra high field MRI. II: acquisition of spin echo images from the human head. , 1999, Journal of computer assisted tomography.

[13]  T. Mikkelsen,et al.  Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated Glioma , 2001, Neurosurgery.

[14]  R. Goebel,et al.  7T vs. 4T: RF power, homogeneity, and signal‐to‐noise comparison in head images , 2001, Magnetic resonance in medicine.

[15]  Petra Schmalbrock,et al.  Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. , 2002, AJNR. American journal of neuroradiology.

[16]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[17]  C. Daumas-Duport Commentary on the WHO Classification of Tumors of the Nervous System , 2002 .

[18]  Petra Schmalbrock,et al.  MR imaging visualization of the cerebral microvasculature: a comparison of live and postmortem studies at 8 T. , 2003, AJNR. American journal of neuroradiology.

[19]  Edward Pan,et al.  Glioblastoma Multiforme and Anaplastic Astrocytoma , 2003 .

[20]  Donald W Chakeres,et al.  Limits of 8‐Tesla magnetic resonance imaging spatial resolution of the deoxygenated cerebral microvasculature , 2004, Journal of magnetic resonance imaging : JMRI.

[21]  Petra Schmalbrock,et al.  Susceptibility-based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. , 2004, AJNR. American journal of neuroradiology.

[22]  Petra Schmalbrock,et al.  Clinical Magnetic Resonance Imaging of Brain Tumors at Ultrahigh Field: A State-of-the-Art Review , 2006, Topics in magnetic resonance imaging : TMRI.

[23]  Matt A Bernstein,et al.  Imaging artifacts at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.

[24]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[25]  S. Kesari,et al.  Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma , 2008, Journal of Neuro-Oncology.

[26]  Zang-Hee Cho,et al.  Observation of the Lenticulostriate Arteries in the Human Brain In Vivo Using 7.0T MR Angiography , 2008, Stroke.

[27]  G. Tedeschi,et al.  Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas , 2008, La radiologia medica.